Rockefeller Financial Services’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Rockefeller Financial Services’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$18.2M	Buy	353,983 +352,719	+27,905%	+$25.3M	0.29%	82
2017 Q3	$113K	Sell	1,264 -103	-8%	-$7.82K	﹤0.01%	374
2017 Q2	$82K	Hold	1,367	–	–	﹤0.01%	355
2017 Q1	$73K	Sell	1,367 -121	-8%	-$7.18K	﹤0.01%	381
2016 Q4	$74K	Hold	1,488	–	–	﹤0.01%	397
2016 Q3	$89K	Buy	+1,488	New	+$85.8K	﹤0.01%	360

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rockefeller Financial Services's ONCE Position: Q4 2017 in Review

Rockefeller Financial Services increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 27,905% in Q4 2017, buying an estimated $25.3M and bringing the position to 353,983 shares worth $18.2M. The position accounts for 0.29% of the portfolio, ranked #82.

Rockefeller Financial Services first reported a position in ONCE in Q3 2016 and has held it in 6 quarters since. 160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

Rockefeller Financial Services held 353,983 shares of Spark Therapeutics, Inc. Common Stock worth $18.2M as of Q4 2017.
Rockefeller Financial Services bought 352,719 Spark Therapeutics, Inc. Common Stock shares in Q4 2017, an estimated $25.3M.
Spark Therapeutics, Inc. Common Stock made up 0.29% of Rockefeller Financial Services's portfolio in Q4 2017, its #82 holding.
Rockefeller Financial Services first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and has held it in 6 quarters since.
160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.